REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

Current tag:

Horizon Discovery: Mitigating risks and developing the U.S. business

Tasks ahead for Eric Rhodes, the new CTO

(C) Horizon Discovery 2012 25-01-2012. Eric T. Rhodes has been appointed CTO of Horizon Discovery. His task is to mitigate major risks for the company’s business, in particular in the US which is the most mature market for the company’s products. B2Bioworld took a closer look at the strategy the new CTO has to implement.

Bayer AG: New Stakes in Stem Cells

Prof. Andreas Busch, Member of the Bayer HealthCare Executive Committee, responsible for Global Drug Discovery

Stem Cells - Failings and Deliveries

Hugh Ilyine, former COO of Stem Cell Sciences

Drug Testing with Embryonic Stem Cells

– Towards Standards For Assays

System Biology: In search of good questions

Walter Kolch on the approach taken by Systems Biology Ireland

Pfizer Regenerative Medicine: “It really started last year…”

Dr Ruth McKernan, the global CSO of Pfizer’s activities in the field, an evaluation of toxicity

Preparing for Another Level of Innovation

Dr Mark Fishman, President of the Novartis Institutes for BioMedical Research and Member of the Executive Committee of Novartis

Doing our business a little bit differently than the others in industry

Dr. Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer of Novo Nordisk

Triggering Regenerative Functions with Transplanted Cells and Small Molecules

Prof. Kurt Stoeckli, Global Head of Biological Sciences / Discovery Sanofi Aventis and Scientific Director of the research site at Vitry-Alfortville

We are obliged to more and more move away from animal models

Prof. Andreas Barner, Chairman of the Board of Managing Directors of Boehringer Ingelheim

Stem Cells: a discovery tool and a potential therapeutic modality

Dr Jonathan Knowles, Former Member of the Roche Executive Committee and Head of Group Research

Stem Cell Insights Collection 2010

Issues and Evaluation from Pharma Leaders

If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.